These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28109554)

  • 1. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
    Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in neutropenic patients with haematological malignancies.
    Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
    Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.
    Chen CY; Tsay W; Tang JL; Tien HF; Chen YC; Chang SC; Hsueh PR
    Epidemiol Infect; 2010 Jul; 138(7):1044-51. PubMed ID: 19941686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
    Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
    Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
    Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
    BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
    Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
    Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
    Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
    Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream Infections in Hospitalized Children: Epidemiology and Antimicrobial Susceptibilities.
    Larru B; Gong W; Vendetti N; Sullivan KV; Localio R; Zaoutis TE; Gerber JS
    Pediatr Infect Dis J; 2016 May; 35(5):507-10. PubMed ID: 26766146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
    Wang L; Wang Y; Fan X; Tang W; Hu J
    Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years.
    Peri AM; Edwards F; Henden A; Harris PNA; Chatfield MD; Paterson DL; Laupland KB
    Clin Exp Med; 2023 Dec; 23(8):4563-4573. PubMed ID: 37815735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
    Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
    Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies.
    Bastug A; Kayaaslan B; Kazancioglu S; But A; Aslaner H; Akinci E; Yetkin MA; Kanyilmaz D; Eren SS; Bodur H
    J Infect Dev Ctries; 2015 Oct; 9(10):1100-7. PubMed ID: 26517485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal nosocomial bloodstream infections at a referral hospital in a middle-income country: burden, pathogens, antimicrobial resistance and mortality.
    Dramowski A; Madide A; Bekker A
    Paediatr Int Child Health; 2015 Aug; 35(3):265-72. PubMed ID: 25940506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years.
    Haddad S; Jabbour JF; Hindy JR; Makki M; Sabbagh A; Nayfeh M; Boustany M; El-Zein S; Tamim H; Zakhem AE; El Cheikh J; Bazarbachi A; Kanj SS
    J Glob Antimicrob Resist; 2021 Dec; 27():228-235. PubMed ID: 34607062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
    Cherif H; Kronvall G; Björkholm M; Kalin M
    Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study.
    Saravu K; Prasad M; Eshwara VK; Mukhopadhyay C
    Pathog Glob Health; 2015 Jul; 109(5):228-35. PubMed ID: 26184918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.